Clinical Trials Directory

Trials / Completed

CompletedNCT01941238

Incidence of Hypoglycemia During Ramadan in Patients With Type1 Diabetes on Insulin Pump Versus Multi Dose Injection

Incidence of Hypoglycemia During Ramadan in Patients With Type1 Diabetes on Insulin Pump Versus Multi-dose Insulin Injection

Status
Completed
Phase
Study type
Observational
Enrollment
142 (actual)
Sponsor
Reem Mohammad Alamoudi · Academic / Other
Sex
All
Age
14 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Managing patients with type1 diabetes when fasting Ramadan is very challenging. Insulin pump offers the advantage of flexibility and precision to administering insulin and has been proven to reduce severe hypoglycemia compared to multi-dose injection (MDI). However, there are extremely limited studies on the difference between insulin pump compared to MDI on the incidence of hypoglycemia and other acute complications during fasting Ramadan The investigators hypothesized that insulin pump would be associated with less hypoglycemic events during fasting Ramadan compared to MDI without deterioration in glycemic control. Results of this study are descriptive but will fill a current gap in knowledge and may contribute to development of future guidelines for the management of type1DM during Ramadan.

Conditions

Timeline

Start date
2013-07-01
Primary completion
2013-09-01
Completion
2014-11-01
First posted
2013-09-13
Last updated
2015-04-07

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT01941238. Inclusion in this directory is not an endorsement.